Dynamics of Minimal Residual Leukemia After Combinations of the HyperCVAD Regimen with Imatinib or Dasatinib In Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia.

被引：0
|
作者：
Ravandi, Farhad
Thomas, Deborah A.
O'Brien, Susan
Faderl, Stefan [1 ]
Jorgensen, Jeffrey [2 ]
Luthra, Rajyalakshmi
Jones, Dan [3 ]
Garris, Rebecca
Cortes, Jorge E.
Kantarjian, Hagop
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Unit 428, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[3] Quest Diagnost, Chantilly, VA USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：879 / 879
页数：1
相关论文
共 50 条
  • [1] MINIMAL RESIDUAL DISEASE AFTER THERAPY FOR PHILADELPHIA-CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
    MARKS, DI
    CROSS, NCP
    FENG, L
    VANRHEE, F
    GOLDMAN, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 : 3 - 3
  • [2] Dasatinib for a child with Philadelphia chromosome-positive acute lymphoblastic leukemia and persistently elevated minimal residual disease during imatinib therapy
    Wu, K. H.
    Wu, H. P.
    Weng, T.
    Peng, C. T.
    Chao, Y. H.
    CURRENT ONCOLOGY, 2015, 22 (04) : 303 - 306
  • [3] PHILADELPHIA-CHROMOSOME POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    PRIEST, JR
    ROBISON, LL
    MCKENNA, RW
    LINDQUIST, LL
    WARKENTIN, PI
    LEBIEN, TW
    WOODS, WG
    KERSEY, JH
    COCCIA, PF
    NESBIT, ME
    BLOOD, 1980, 56 (01) : 15 - 22
  • [4] MINIMAL RESIDUAL DISEASE MONITORING IN PATIENTS WITH PHILADELPHIA-CHROMOSOME POSITIVE (PH1) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) TREATED WITH THE COMBINATION OF HYPERCVAD AND A TYROSINE KINASE INHIBITOR
    Ravandi, F.
    Thomas, D.
    O'Brien, S.
    Faderl, S.
    Jorgensen, J.
    Luthra, R.
    Kebriaei, P.
    Garris, R.
    Cortes, J.
    Kantarjian, H.
    ANNALS OF ONCOLOGY, 2011, 22 : 223 - 224
  • [5] Phase II Study of Combination of the Hypercvad Regimen with Dasatinib in the Front Line Therapy of Patients with Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Thomas, Deborah A.
    Faderl, Stefan
    Jones, Dan
    Koller, Charles A.
    Dara, Samuel
    Garris, Rebecca
    Kebriaei, Partow
    Champlin, Richard
    Borthakur, Gautam
    Wierda, William G.
    Burger, Jan A.
    Cortes, Jorge
    O'Brien, Susan
    BLOOD, 2009, 114 (22) : 345 - 345
  • [6] Mechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemia
    Hofmann, WK
    Komor, M
    Hoelzer, D
    Ottmann, OG
    LEUKEMIA & LYMPHOMA, 2004, 45 (04) : 655 - 660
  • [7] Phase II trial of HyperCVAD and Dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia
    Benjamini, Ohad
    Dumlao, Theresa Liu
    Kantarjian, Hagop
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Faderl, Stefan
    Jorgensen, Jeffrey
    Luthra, Rajyalakshmi
    Garris, Rebecca
    Thomas, Deborah
    Kebriaei, Partow
    Champlin, Richard
    Jabbour, Elias
    Burger, Jan
    Cortes, Jorge
    Ravandi, Farhad
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (03) : 282 - 287
  • [8] Detection of Minimal Residual Leukemia Predicts the Outcome of Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia Treated with Tyrosine Kinase Inhibitors Plus Chemotherapy
    Ravandi, Farhad
    Thomas, Deborah A.
    O'Brien, Susan
    Garris, Rebecca
    Faderl, Stefan
    Shan, Jianqin
    Borthakur, Gautam
    Burger, Jan A.
    Ferrajoli, Alessandra
    Kebriaei, Partow
    Champlin, Richard
    Estrov, Zeev
    Wang, Sa A.
    Jorgensen, Jeffrey L.
    Luthra, Rajyalakshmi
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    BLOOD, 2011, 118 (21) : 631 - 632
  • [9] PHILADELPHIA-CHROMOSOME POSITIVE CHRONIC MYELOGENOUS LEUKEMIA DEVELOPING IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    KELSEN, DP
    GEE, TS
    CHAGANTI, RSK
    CANCER, 1979, 43 (05) : 1782 - 1787
  • [10] Dasatinib - In chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
    Keam, Susan J.
    BIODRUGS, 2008, 22 (01) : 59 - 69
12345